山西康乐佰顺药业有限公司
ZHEJIANG SHENZHOU PHARMACEUTICAL CO.,LTD.
Home
About us
Company profile
Video
Products
Manufacturing
Quality
News
Industry News
Company News
Contact us
简体中文
New drug development in China: How far are we from the first original drug?
According to a data provided by Tufts Center for Drug Development Research, the average cost of developing a new drug is about US$2.6 billion. 17.8% of the global top 10 pharmaceutical companies invested in R&D as a percentage of sales in 2013, amounting to US$60.39 billion, while the top 10 domestic pharmaceutical companies invested only 1% of sales in R&D, about US$300 million.
18
2022
/
11
[Good News] Zhejiang Shenzhou Pharmaceuticals spironolactone tablets were approved for marketing!
On 25 August, the State Drug Administration (SDA) issued a notification of drug approval for [Spironolactone Tablets], a new Class 3 filing of Zhejiang Shenzhou Pharmaceutical Co. The Company has officially received the approval letter from the State Drug Administration on 6 September.
24
10
Notice on the issuance of the National Shortage Drug List Management Measures (for trial implementation)
All provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps Health and Health Commission, Development and Reform Commission, Industry and Information Technology Department, Finance Department (Bureau), Department of Ecology and Environment (Bureau), Commerce Department, State-owned Assets Supervision and Administration Commission, Market Supervision Bureau (Department, Commission), Health Insurance Bureau, Chinese Medicine Bureau, Drug Administration, and relevant units of the military.
What you need to know about herbal medicine
Chinese medicine is the medicine used in Chinese medicine, which is unique to traditional Chinese medicine in China. Chinese medicine is divided into proprietary Chinese medicines and Chinese herbal medicines according to the processing process.